Plant miRNAs for Improved Gene Regulation in a Wide Range of Human Cancers

Maksym Zoziuk1, Vittorio Colizzi2, Pavlo Krysenko3

  • 1Centro Interdipartimentale di Medicina Comparata, Tecniche Alternative ed Acquacoltura, Interdepartmental Center for Comparative Medicine, Alternative Techniques, and Aquaculture, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.

PubMed

Insights

This study identifies plant microRNAs (miRNAs) that can potentially replace deficient human miRNAs in cancer treatment. Findings suggest plant miRNAs may compensate for downregulated regulatory miRNAs in various oncological diseases.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • MicroRNA (miRNA) expression is crucial for understanding cancer development.
  • Identifying correlations between miRNA expression, target genes, and cancer is vital for research.
  • Plant-derived miRNAs offer potential therapeutic avenues for cancer treatment.

Purpose of the Study:

  • To grade human miRNAs by expression levels across all cancer types.
  • To identify potential plant-based miRNA substitutes for deficient human miRNAs.
  • To explore the feasibility of using plant miRNAs for compensating regulatory miRNA deficiencies in oncological diseases.

Main Methods:

  • Analysis of a comprehensive database of human miRNA expression.
  • Comparison of downregulated human miRNAs with their target genes.
  • Identification of plant miRNAs with high complementarity to under-expressed human miRNAs.

Main Results:

  • Downregulated miRNAs were found to be 2.5 times more prevalent than upregulated miRNAs.
  • No significant direct correlation was observed between miRNA and gene expression.
  • Plant miRNAs were identified as potential substitutes for deficient human miRNAs.

Conclusions:

  • Plant miRNAs show promise in compensating for insufficient regulatory miRNA expression in human and animal cancers.
  • Further experimental verification is needed to confirm the therapeutic potential of plant-derived miRNA replacement.
  • The findings open new possibilities for novel cancer therapies targeting miRNA dysregulation.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K